SCHEMBL13560937

SCHEMBL13560937

CCNc1ccc(N)c(C)c1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
MAPT P10636 2/20 0.49
THRB P10828 2/20 0.49
KDM4E B2RXH2 1/20 0.49
GAA P10253 1/20 0.49
HPGD P15428 1/20 0.49
HTT P42858 1/20 0.49
GFER P55789 1/20 0.49
PLEC Q15149 1/20 0.49
LMNA P02545 1/20 0.40
CYP3A4 P08684 3/20 0.38
TSHR P16473 2/20 0.38
RECQL P46063 1/20 0.38
IDO1 P14902 2/20 0.37
PIK3CA P42336 1/20 0.37
AOC1 P19801 2/20 0.34
AOC3 Q16853 2/20 0.34
HCAR3 P49019 1/20 0.33
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27686457 0.98 ALDH1A1 (0.47) ALDH1A1MAPTTHRBKDM4EGAA
SCHEMBL8898753 0.81 CYP3A4 (0.52) ALDH1A1MAPTTHRBKDM4EGAA
SCHEMBL28621184 0.79 HCAR3 (0.40) HCAR3HDAC6
SCHEMBL28636219 0.77 PRSS1 (0.41) HCAR3HDAC6
SCHEMBL28615286 0.77 PRSS1 (0.41) HCAR3HDAC6
SCHEMBL16867408 0.77 CYP3A4 (0.50) ALDH1A1MAPTTHRBKDM4EGAA
SCHEMBL8036530 0.76 KDM4E (0.41) ALDH1A1MAPTTHRBKDM4EGAA
SCHEMBL10433150 0.76 KDM4E (0.41) ALDH1A1MAPTTHRBKDM4EGAA
SCHEMBL6270848 0.76 CYP3A4 (0.39) ALDH1A1MAPTTHRBKDM4EGAA
SCHEMBL2273254 0.74 CYP3A4 (0.38) ALDH1A1MAPTTHRBKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103641794-B Sulfonium compound and application thereof 维斯塔实验室有限公司 2016-09-21 CN disclosed
CN-101460157-B protein aggregation inhibitors WISTA LABORATORIES LTD. (SG) 2015-09-02 CN disclosed
CN-103735554-A Inhibitors of protein aggregation WISTA LAB LTD 2014-04-23 CN disclosed
CN-103641794-A Sulfonium compounds and their use WISTA LAB LTD 2014-03-19 CN disclosed
CN-101460222-B Sulfonium compounds and their use WISTA LAB LTD 2013-12-04 CN disclosed
US-8507546-B2 Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases INSTITUTO DE MEDICINA MOLECULAR, FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA (PT) 2013-08-13 US disclosed
US-8507546-B2 Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases INSTITUTO DE MEDICINA MOLECULAR, FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA (PT) 2013-08-13 US disclosed
US-20120276121-A1 USE OF INHIBITORS OF SCAVENGER RECEPTOR CLASS PROTEINS FOR THE TREATMENT OF INFECTIOUS DISEASES INSTITUTO DE MEDICINA MOLECULAR, FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA (PT) 2012-11-01 US disclosed
US-20120276121-A1 USE OF INHIBITORS OF SCAVENGER RECEPTOR CLASS PROTEINS FOR THE TREATMENT OF INFECTIOUS DISEASES INSTITUTO DE MEDICINA MOLECULAR, FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA (PT) 2012-11-01 US disclosed
US-20090324580-A1 Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases CENIX BIOSCIENCE GMBH (DE) 2009-12-31 US disclosed
US-20090324580-A1 Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases CENIX BIOSCIENCE GMBH (DE) 2009-12-31 US disclosed
CN-101460222-A Sulfonium compounds and their use WISTA LAB LTD (SG) 2009-06-17 CN disclosed
CN-101460157-A Protein aggregation inhibitors WISTA LAB LTD (SG) 2009-06-17 CN disclosed
CN-1010347-B Method for improving ammonia development rate of diazo blueprint paper STATE CHANGSH CHEMICAL PHOTOGR (CN) 1990-11-07 CN disclosed
CN-1030828-A Improve the method for ammonia developing rate of heavy-nitrogen printing paper STATE OWNED CHANGSHA CHEMICAL (CN) 1989-02-01 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090324580-A1 Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases SCARB1, MSR1, HAVCR2 ALDH1A1 511/4885MAPT 4202/4885THRB 901/4885
US-20120276121-A1 USE OF INHIBITORS OF SCAVENGER RECEPTOR CLASS PROTEINS FOR THE TREATMENT OF INFECTIOUS DISEASES SCARB1, MSR1, HAVCR2 ALDH1A1 511/4885MAPT 4202/4885THRB 901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.